Jones PH - Search Results

1

Chemical modifications of erythromycin antibiotics. I. 3'-de(dimethylamino)erythromycin A and B.

Jones PH, Rowley EK. Jones PH, et al. J Org Chem. 1968 Feb;33(2):665-70. doi: 10.1021/jo01266a041. J Org Chem. 1968. PMID: 5636610 No abstract available.

2

Chemical modifications of erythromycin antibiotics. 3. Synthesis of 4" and 11 esters of erythromycin A and B.

Jones PH, Perun TJ, Rowley EK, Baker EJ. Jones PH, et al. J Med Chem. 1972 Jun;15(6):631-4. doi: 10.1021/jm00276a017. J Med Chem. 1972. PMID: 5030931 No abstract available.

3

Insoluble erythromycin salts.

Jones PH, Rowley E, Weiss AL, Bishop DL, Chun AH. Jones PH, et al. J Pharm Sci. 1969 Mar;58(3):337-9. doi: 10.1002/jps.2600580311. J Pharm Sci. 1969. PMID: 5782028 No abstract available.

4

Chemical modifications of erythromycin antibiotics. II. Synthesis of 4'-hydroxyerythromycin A.

Jones PH, Iyer KS, Grundy WE. Jones PH, et al. Antimicrob Agents Chemother (Bethesda). 1969;9:123-30. Antimicrob Agents Chemother (Bethesda). 1969. PMID: 5396478 No abstract available.

5

Conformation of mactolide antibiotics. IV. Nuclear magnetic resonance, circular dichroism, and chemical studies of erythromycin derivatives.

Perun TJ, Egan RS, Jones PH, Martin JR, Mitscher LA, Slater BJ. Perun TJ, et al. Among authors: jones ph. Antimicrob Agents Chemother (Bethesda). 1969;9:116-22. Antimicrob Agents Chemother (Bethesda). 1969. PMID: 5396476 No abstract available.

6

Chemical modification of erythromycin antibiotics. 4. Structure-activity relationships of erythromycin esters.

Martin YC, Jones PH, Perun TJ, Grundy WE, Bell S, Bower RR, Shipkowitz NL. Martin YC, et al. Among authors: jones ph. J Med Chem. 1972 Jun;15(6):635-8. doi: 10.1021/jm00276a018. J Med Chem. 1972. PMID: 4555493 No abstract available.

7

Acid degradation of erythromycin A and erythromycin B.

Kurath P, Jones PH, Egan RS, Perun TJ. Kurath P, et al. Among authors: jones ph. Experientia. 1971 Apr 15;27(4):362. doi: 10.1007/BF02137246. Experientia. 1971. PMID: 5581079 No abstract available.

8

Risk factors for tick attachment in companion animals in Great Britain: a spatiotemporal analysis covering 2014-2021.

Arsevska E, Hengl T, Singleton DA, Noble PM, Caminade C, Eneanya OA, Jones PH, Medlock JM, Hansford KM, Bonannella C, Radford AD. Arsevska E, et al. Among authors: jones ph. Parasit Vectors. 2024 Jan 22;17(1):29. doi: 10.1186/s13071-023-06094-4. Parasit Vectors. 2024. PMID: 38254168 Free PMC article.

9

Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skin.

Olafsson S, Rodriguez E, Lawson ARJ, Abascal F, Huber AR, Suembuel M, Jones PH, Gerdes S, Martincorena I, Weidinger S, Campbell PJ, Anderson CA. Olafsson S, et al. Among authors: jones ph. Nat Genet. 2023 Nov;55(11):1892-1900. doi: 10.1038/s41588-023-01545-1. Epub 2023 Oct 26. Nat Genet. 2023. PMID: 37884686 Free PMC article.

10

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page